与霍奇金氏淋巴瘤试验相似，试验主要终点是客观缓解率。
Similar to the HL trial, the trial's primary endpoint was objective response rate.
结果：从总临床客观缓解率和主要不良反应上看治疗组明显优于对照组。
Results:From the clinical eficacy and toxicity the treatment group was significantly better than the control group.
研究主要终点是客观缓解率，治疗后经受完全或部分癌症皱缩或消失患者的百分率。
The study’s primary endpoint was objective response rate, the percentage of patients who experienced complete or partial cancer shrinkage or disappearance after treatment.
应用推荐